Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma
Conditions
Hepatocellular Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ippokrateio General Hospital of Athens, Athens, Greece
Laiko General Hospital of Athens, Athens, Greece
General University Hospital of Larissa, Larissa, Greece
University General Hospital of Thessaloniki - AHEPA, Thessaloniki, Greece
Rambam Health Corporation, Haifa, Israel
Rabin Medical Center - Beilinson Hospital, Petah Tikva, Israel
The Sheba Academic Medical Center Hospital - Tel Hashomer, Ramat Gan, Israel
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Istituto Clinico Humanitas, Rozzano, MI, Italy
AOU S. Orsola Malpighi Bologna, Bologna, Italy
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
Azienda Ospedaliera Universitaria Policlinico di Modena, Modena, Italy
A.O.U. Federico II, Naples, Italy
A.O. U. Policlinico Paolo Giaccone, Palermo, Italy
Study leads
Fayez M Hamzeh, MD
Study Chair
Tiziana Life Sciences LTD
Angelo Sangiovanni, MD, PHD
Principal Investigator
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico - Milano, Italy
Armando Santoro, MD
Principal Investigator
Istituto Clinico Humanitas - Rozzano (MI), Italy